Table: begin end state 1 11 cytoplasmic 12 31 transmembrane 32 51 non-cytoplasmic 52 72 transmembrane 73 83 cytoplasmic 84 101 transmembrane 102 105 non-cytoplasmic 106 129 transmembrane 130 149 cytoplasmic 150 171 transmembrane 172 190 non-cytoplasmic 191 211 transmembrane 212 253 cytoplasmic 254 276 transmembrane 277 295 non-cytoplasmic 296 320 transmembrane 321 328 cytoplasmic 329 348 transmembrane 349 353 non-cytoplasmic 354 378 transmembrane 379 388 cytoplasmic 389 415 transmembrane 416 420 non-cytoplasmic 421 442 transmembrane 443 451 cytoplasmic
Input: >Echvi_2841 FitnessBrowser__Cola:Echvi_2841 MQAQIEKKKLSFWQIWNMSFGFLGIQMGFALQNANASRILQTFGADVEHLSLFWLVAPIT GMIIQPIIGHYSDRTWTKLGRRRPYFLAGAVLAAIGLVLMPNASLFVAYLPALWVGAGFL MIMDASFNVAMEPFRALVADKLPTDQRTLGFAVQTLLIGLGAVIGSWLPYVLTEWFSIPT TANEGIVPQNVLWAFIIGATILVASILWTVLRTSEYPPDELEKSAHKIDKNAQRGLSSIF TDFIKMPKTMKQLGLVQFFSWFALFSMWVFSTPALAQHVWGLPSSDRSSLEFNEAGNYVG VIFGVYNLVSALFAMTLPVIAAKIGRKMTHAICLLIGGTGLISILWVTDPEMKWVLNLSM IGVGIAWASILAMPYAILAGSIPAKKMGVYMGIFNFFITAPQILNGFIGGWIVRYIYGGQ AIYALFSAGLFLILAAMLTYFVEDKDDGAIA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server